HRT Financial’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-74,491
| Closed | -$2.44M | – | 3184 |
|
|
2025
Q1 | $2.44M | Buy |
+74,491
| New | +$2.44M | 0.02% | 613 |
|
|
2023
Q4 | – | Sell |
-56,739
| Closed | -$1.56M | – | 2814 |
|
|
2023
Q3 | $1.56M | Buy |
56,739
+35,145
| +163% | +$969K | 0.02% | 671 |
|
|
2023
Q2 | $649K | Sell |
21,594
-27,870
| -56% | -$838K | 0.01% | 1114 |
|
|
2023
Q1 | $1.79M | Buy |
49,464
+18,183
| +58% | +$659K | 0.02% | 617 |
|
|
2022
Q4 | $1.12M | Sell |
31,281
-21,317
| -41% | -$760K | 0.02% | 834 |
|
|
2022
Q3 | $1.78M | Buy |
52,598
+40,757
| +344% | +$1.38M | 0.02% | 626 |
|
|
2022
Q2 | $342K | Buy |
+11,841
| New | +$342K | ﹤0.01% | 1879 |
|
|
2022
Q1 | – | Sell |
-80,576
| Closed | -$2.35M | – | 3513 |
|
|
2021
Q4 | $2.35M | Buy |
80,576
+59,202
| +277% | +$1.73M | 0.01% | 522 |
|
|
2021
Q3 | $570K | Buy |
+21,374
| New | +$570K | ﹤0.01% | 1680 |
|
|
2020
Q3 | – | Sell |
-14,282
| Closed | -$339K | – | 2216 |
|
|
2020
Q2 | $339K | Buy |
+14,282
| New | +$339K | 0.01% | 833 |
|